Skip to content
etfnews.live

Company

Enanta Pharmaceuticals

United States

The ETFs we cover that hold this company, and its latest news.

Which ETFs hold Enanta Pharmaceuticals?

Held by 43 covered funds. Sorted by Enanta Pharmaceuticals’ share of each fund. Holdings as of each fund’s latest SEC filing.

FundShare of fund
QQQSInvesco NASDAQ Future Gen 2000.4%
DWASInvesco Dorsey Wright SmallCap Momentum0.3%
GCAVXGMO U.S. Small Cap Value Fund0.1%
FSMLFranklin Small Cap Enhanced0.1%
IWCiShares Micro-Cap0.1%
FSEVFidelity Enhanced Small Cap Value0.1%
FSEGFidelity Enhanced Small Cap Growth0.1%
FEACFidelity Enhanced U.S. All-Cap Equity0.1%
VFMOVanguard U.S. Momentum Factor0.1%
RFLRInnovator U.S. Small Cap Managed Floor0.0%
IBBiShares Biotechnology0.0%
IBBQInvesco Nasdaq Biotechnology0.0%
QOWZInvesco Nasdaq Free Cash Flow Achievers0.0%
VTWVVanguard Russell 2000 Value Index Fund0.0%
PRFZInvesco Rafi US 1500 Small-Mid0.0%
IWNiShares Russell 2000 Value0.0%
NSIDXSmall Cap Index Fund0.0%
IWMiShares Russell 20000.0%
IWOiShares Russell 2000 Growth0.0%
RSSLGlobal X Russell 20000.0%
VTWOVanguard Russell 2000 Index Fund0.0%
ITWOProShares Russell 2000 High Income0.0%
RBProShares Russell 2000 Dynamic Buffer0.0%
DFSCXU.S. Micro Cap Portfolio0.0%
SCHASchwab U.S. Small-Cap0.0%
DFASDimensional U.S. Small Cap0.0%
SSMHXState Street Small/mid Cap Equity Index Portfolio0.0%
VXFVanguard Extended Market Index Fund0.0%
MSSMMorgan Stanley Pathway Small-Mid Cap Equity0.0%
AVSUAvantis Responsible U.S. Equity0.0%
DCORDimensional US Core Equity 10.0%
ITOTiShares Core S&P Total U.S. Stock Market0.0%
VTIVanguard Total Stock Market Index Fund0.0%
DFAUDimensional US Core Equity Market0.0%
KCXSXKnights of Columbus U.S. ALL CAP INDEX FUND0.0%
VITPXVanguard Institutional Total Stock Market Index Fund0.0%
VTHRVanguard Russell 3000 Index Fund0.0%
IWViShares Russell 30000.0%
SCHBSchwab U.S. Broad Market0.0%
DFQTXU.S. Core Equity 2 Portfolio0.0%
DFUSDimensional U.S. Equity Market0.0%
AVTMAvantis Total Equity Markets0.0%
DFACDimensional U.S. Core Equity 20.0%

Where to buy these ETFs

[Affiliate and risk wording from the law firm]

Latest Enanta Pharmaceuticals news

No recent stories about Enanta Pharmaceuticals.